Atopic dermatitis, commonly known as eczema, is a chronic inflammatory dermatosis that can affect individuals from infancy to adulthood. Also referred to as "the itch that rashes", atopic dermatitis is classically associated with significant pruritus that is accompanied by characteristic cutaneous and ...
ACAAI Presentation Highlights Roflumilast’s Efficacy and Safety Maddi Hebebrand, MC, Associate Editor October 24th 2024 Findings from 2 phase 3 trials indicate that ZORYVE cream significantly improves both clinical outcomes and quality of life in patients with mild to moderate atopic dermatitis. ...
Zirwas described several highlights from his presentation on updates in managing atopic dermatitis, describing examples such as lebrikizumab and nemolizumab. Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD ByTim Smith ...
Atopic dermatitis (AD) is a common chronic inflammatory skin disease with a complex pathophysiology that underlies a wide spectrum of clinical phenotypes. AD remains challenging to treat owing to the limited response to available therapies. However, recent advances in understanding of disease mechanisms...
Atopic Dermatitis (AD) is a heterogeneous disorder with a wide spectrum of clinical signs, symptoms, severity and clinical course. Consequently, there is no single tool that comprehensively assesses all aspects of the disease. There are presently >60 measures that have been used to assess the sev...
Clinical presentation Classification of atopic dermatitis Atopic dermatitisis characterized by severe pruritus, a chronically relapsing course, a distinctive distribution of eczematous skin lesions, and a personal or family history of atopic diseases. It often begins in early infancy and follows a course ...
Clinical Presentation References Jansén CT, Haapalahti J, Hopsu-Havu VK. Immunoglobulin E in the human atopic skin. Arch Dermatol Forsch. 1973 May 28. 246 (4):209-302. [QxMD MEDLINE Link]. Spergel JM. From atopic dermatitis to asthma: the atopic march. Ann Allergy Asthma Immunol. 20...
Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies 2021, Journal of the American Academy of Dermatology Show abstract JAK inhibitors in the treatment of atopic dermatitis 2021, Journal of Allergy and Clinical Immu...
Atopic dermatitis (AD) is a genetically determinated, chronic inflammatory skin disorder associated with cutaneous erythema and severe pruritus, affecting 10-15% of children with increasing incidence and socio-economical relevance. Frequently, AD is associated with development of allergic rhinitis and/or ...
Atopic dermatitis (AD) is a chronic and pruritic inflammatory skin disorder that has a relapsing course and can affect any age group. Patients with AD have higher rates of other allergic disorders, mental health disorders, and skin infections. An important feature of AD for practitioners to recog...